Antioxidant status of Fanconi anemia fibroblasts - PubMed (original) (raw)

• PMID: 3623559
• DOI: 10.1007/BF00284708

Antioxidant status of Fanconi anemia fibroblasts

J J Gille et al. Hum Genet. 1987 Sep.

Abstract

Several observations in the recent literature have indicated that Fanconi anemia (FA) cells may be primarily deficient in the detoxification of activated oxygen species. To evaluate the antioxidant status of FA fibroblasts, we measured Mn-containing superoxide dismutase (Mn-SOD), CuZn-containing superoxide dismutase (CuZn-SOD), catalase, and glutathione peroxidase activities, as well as cellular glutathione contents and total nonenzymatic antioxidant potential in FA and control fibroblasts at multiple time points during a single passage. All parameters exhibited a characteristic pattern of changes during a period of 19 days following trypsinization. Unlike FA erythrocytes, which are known to be deficient in CuZn-SOD, FA fibroblasts exhibited normal CuZn-SOD activities. Also, the nonenzymatic "antioxidant potential" as well as glutathione levels were similar in FA and control fibroblasts. However, Mn-SOD, catalase, and glutathione peroxidase activities were consistently higher in FA fibroblasts. We hypothesize that the elevation of these enzyme activities might reflect a cellular "prooxidant" state in FA resulting from an increased formation of endogenous oxidizing molecular species that trigger enhanced synthesis of certain enzymatic antioxidant defenses.

PubMed Disclaimer

Similar articles

• The role of oxygen metabolism for the pathological phenotype of Fanconi anemia.
  Ruppitsch W, Meisslitzer C, Weirich-Schwaiger H, Klocker H, Scheidereit C, Schweiger M, Hirsch-Kauffmann M. Ruppitsch W, et al. Hum Genet. 1997 Jun;99(6):710-9. doi: 10.1007/s004390050437. Hum Genet. 1997. PMID: 9187662
• Antioxidant enzymes in psoriatic fibroblasts and erythrocytes.
  Thérond P, Gerbaud P, Dimon S, Anderson WB, Evain-Broin D, Raynaud F. Thérond P, et al. J Invest Dermatol. 1996 Jun;106(6):1325-8. doi: 10.1111/1523-1747.ep12349055. J Invest Dermatol. 1996. PMID: 8752678
• Decreased superoxide dismutase activity of erythrocytes and leukocytes in Fanconi's anemia.
  Yoshimitsu K, Kobayashi Y, Usui T. Yoshimitsu K, et al. Acta Haematol. 1984;72(3):208-10. doi: 10.1159/000206389. Acta Haematol. 1984. PMID: 6438987
• CuZn superoxide dismutase, Mn superoxide dismutase, catalase and glutathione peroxidase in glutathione-deficient human fibroblasts.
  Marklund SL, Midander J, Westman G. Marklund SL, et al. Biochim Biophys Acta. 1984 Apr 24;798(3):302-5. doi: 10.1016/0304-4165(84)90102-8. Biochim Biophys Acta. 1984. PMID: 6712993

Cited by

• Fanconi anemia mutation causes cellular susceptibility to ambient oxygen.
  Schindler D, Hoehn H. Schindler D, et al. Am J Hum Genet. 1988 Oct;43(4):429-35. Am J Hum Genet. 1988. PMID: 3177386 Free PMC article.
• Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells.
  Segal GM, Magenis RE, Brown M, Keeble W, Smith TD, Heinrich MC, Bagby GC Jr. Segal GM, et al. J Clin Invest. 1994 Aug;94(2):846-52. doi: 10.1172/JCI117405. J Clin Invest. 1994. PMID: 7518843 Free PMC article.
• Fanconi anemia proteins and their interacting partners: a molecular puzzle.
  Kaddar T, Carreau M. Kaddar T, et al. Anemia. 2012;2012:425814. doi: 10.1155/2012/425814. Epub 2012 Mar 29. Anemia. 2012. PMID: 22737580 Free PMC article.
• Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.
  Porfirio B, Ambroso G, Giannella G, Isacchi G, Dallapiccola B. Porfirio B, et al. Hum Genet. 1989 Aug;83(1):49-51. doi: 10.1007/BF00274146. Hum Genet. 1989. PMID: 2767678
• Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.
  Poot M, Hoehn H. Poot M, et al. Hum Genet. 1990 May;84(6):581-3. doi: 10.1007/BF00210816. Hum Genet. 1990. PMID: 2338346 No abstract available.

References

1. 1. Hum Genet. 1983;65(2):99-101 - PubMed
2. 1. Biochim Biophys Acta. 1984 Apr 24;798(3):302-5 - PubMed
3. 1. J Mol Biol. 1977 Jul 15;113(4):635-49 - PubMed
4. 1. Scand J Clin Lab Invest. 1979 Dec;39(8):759-64 - PubMed
5. 1. Cytogenet Cell Genet. 1982;33(1-2):119-32 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information